Magazine: Cell and gene therapy approvals drive paradigm change in manufacturing
The growing global demand for cell and gene therapies (CGTs) is resulting in a manufacturing paradigm shift, reflecting the need…
Features
Social media algorithms are driving the GLP-1 drugs boom
Blockchain leaders finesse tech to find fake drugs
Compounding pharmacies caught in counterfeit controversy
Iterum’s oral sulopenem acceptance hinges on antibiotic stewardship efforts
AI boom set to revolutionise healthcare in Europe
Magazine: Enhancing therapy adherence with prodrugs
After the Lykos debacle, what’s next for psychedelic therapies?
